The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Scimeca Dario since 2022.
This trader's CIK number is 1779581.
At the time of last reporting, Scimeca Dario was the General Counsel and Secretary of Precision Biosciences Inc. (stock ticker symbol DTIL).
Also see all insider trading activities at Precision Biosciences Inc.
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2025 | DTIL | 0 | $0 | 9,200 | $44,100 | 26,231 | $0 |
| 2024 | DTIL | 0 | $0 | 22,240 | $16,381 | 62,400 | $0 |
| 2023 | DTIL | 0 | $0 | 41,556 | $29,453 | 114,406 | $0 |
| 2022 | DTIL | 0 | $0 | 9,833 | $20,255 | 31,774 | $0 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2025-03-03 | DTIL | Option Ex | 919 | .00 | 0 |
| 2025-03-04 | DTIL | Sale | 272 | 4.91 | 1,335 |
| 2025-01-20 | DTIL | Option Ex | 25,312 | .00 | 0 |
| 2025-01-22 | DTIL | Sale | 8,928 | 4.79 | 42,765 |
| 2024-11-04 | DTIL | Sale | 588 | 8.19 | 4,815 |
| 2024-11-02 | DTIL | Option Ex | 1,836 | .00 | 0 |
| 2024-06-07 | DTIL | Option Ex | 301 | .00 | 0 |
| 2024-06-10 | DTIL | Sale | 93 | 11.79 | 1,096 |
| 2024-05-02 | DTIL | Sale | 272 | 10.32 | 2,807 |
| 2024-05-01 | DTIL | Option Ex | 918 | .00 | 0 |
| 2024-01-20 | DTIL | Option Ex | 59,345 | .00 | 0 |
| 2024-01-22 | DTIL | Sale | 21,287 | .36 | 7,663 |
| 2023-11-02 | DTIL | Option Ex | 55,077 | .00 | 0 |
| 2023-11-03 | DTIL | Sale | 16,023 | .40 | 6,409 |
| 2023-06-07 | DTIL | Option Ex | 31,771 | .00 | 0 |
| 2023-06-08 | DTIL | Sale | 13,361 | .75 | 10,020 |
| 2023-03-06 | DTIL | Sale | 12,172 | 1.07 | 13,024 |
| 2023-03-03 | DTIL | Option Ex | 27,558 | .00 | 0 |
| 2022-06-07 | DTIL | Option Ex | 31,774 | .00 | 0 |
| 2022-06-08 | DTIL | Sale | 9,833 | 2.06 | 20,255 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Scimeca Dario (General Counsel and Secretary of Precision Biosciences Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.